Kurma Partners is a Paris-based investment firm founded in 2009 that concentrates on financing innovation in healthcare and biotechnology across Europe. It targets early-stage and development capital for companies in life sciences, biotechnology, digital health, and related fields, and emphasizes collaborations with research institutes and hospitals to advance therapies and medical technologies from concept to clinical development. The firm operates as a specialist investor in Europe, supporting ventures that bridge scientific discovery and patient impact through equity investments and strategic guidance.
Germitec is a healthcare company focused on the design and commercialization of ultraviolet light disinfection systems aimed at enhancing hospital hygiene. By specializing in high-level disinfection using UV-C technology, Germitec provides solutions for reprocessing non-lumen medical devices. The company's innovations are intended to simplify the responsibilities of healthcare professionals, improving safety and efficiency while effectively reducing the risk of cross-infection in clinical settings. Through its advanced disinfection systems, Germitec seeks to transform clinical practices and contribute to better healthcare outcomes.
Hopia
Seed Round in 2025
Hopia is a scheduling solution specifically designed for healthcare institutions, focusing on the optimization of human and material resources. The platform centralizes the management of doctors' and nurses' schedules, employing constrained optimization and prediction algorithms to establish the most efficient organization for all stakeholders involved. By streamlining scheduling processes, Hopia aims to enhance operational efficiency, allowing healthcare personnel to allocate more time to patient care and improve overall service delivery in the healthcare sector.
Germitec
Venture Round in 2022
Germitec is a healthcare company focused on the design and commercialization of ultraviolet light disinfection systems aimed at enhancing hospital hygiene. By specializing in high-level disinfection using UV-C technology, Germitec provides solutions for reprocessing non-lumen medical devices. The company's innovations are intended to simplify the responsibilities of healthcare professionals, improving safety and efficiency while effectively reducing the risk of cross-infection in clinical settings. Through its advanced disinfection systems, Germitec seeks to transform clinical practices and contribute to better healthcare outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.